165 related articles for article (PubMed ID: 15658859)
1. Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.
Ducki S; Mackenzie G; Lawrence NJ; Snyder JP
J Med Chem; 2005 Jan; 48(2):457-65. PubMed ID: 15658859
[TBL] [Abstract][Full Text] [Related]
2. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
ter Haar E; Rosenkranz HS; Hamel E; Day BW
Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
[TBL] [Abstract][Full Text] [Related]
3. Conformationally restricted macrocyclic analogues of combretastatins.
Mateo C; Alvarez R; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Nov; 17(22):6316-20. PubMed ID: 17889536
[TBL] [Abstract][Full Text] [Related]
4. Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones.
Ducki S; Mackenzie G; Greedy B; Armitage S; Chabert JF; Bennett E; Nettles J; Snyder JP; Lawrence NJ
Bioorg Med Chem; 2009 Nov; 17(22):7711-22. PubMed ID: 19837594
[TBL] [Abstract][Full Text] [Related]
5. p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
Álvarez R; López V; Mateo C; Medarde M; Peláez R
J Org Chem; 2014 Aug; 79(15):6840-57. PubMed ID: 24966024
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrotubule activity of combretatropone derivatives.
Janik ME; Bane SL
Bioorg Med Chem; 2002 Jun; 10(6):1895-903. PubMed ID: 11937347
[TBL] [Abstract][Full Text] [Related]
7. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
Liao SY; Chen JC; Miao TF; Shen Y; Zheng KC
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):421-9. PubMed ID: 19874191
[TBL] [Abstract][Full Text] [Related]
8. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R
J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011
[TBL] [Abstract][Full Text] [Related]
9. Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on beta-tubulin.
Brown ML; Rieger JM; Macdonald TL
Bioorg Med Chem; 2000 Jun; 8(6):1433-41. PubMed ID: 10896120
[TBL] [Abstract][Full Text] [Related]
10. The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors.
González M; Ellahioui Y; Álvarez R; Gallego-Yerga L; Caballero E; Vicente-Blázquez A; Ramudo L; Marín M; Sanz C; Medarde M; Pelaéz R
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779228
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and Molecular Docking of Combretastatin and Colchicine Derivatives and their hCE1-Activated Prodrugs as Antiviral Agents.
Richter M; Boldescu V; Graf D; Streicher F; Dimoglo A; Bartenschlager R; Klein CD
ChemMedChem; 2019 Feb; 14(4):469-483. PubMed ID: 30605241
[TBL] [Abstract][Full Text] [Related]
12. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
13. Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents.
Gwaltney SL; Imade HM; Barr KJ; Li Q; Gehrke L; Credo RB; Warner RB; Lee JY; Kovar P; Wang J; Nukkala MA; Zielinski NA; Frost D; Ng SC; Sham HL
Bioorg Med Chem Lett; 2001 Apr; 11(7):871-4. PubMed ID: 11294380
[TBL] [Abstract][Full Text] [Related]
14. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins.
Jiménez C; Ellahioui Y; Álvarez R; Aramburu L; Riesco A; González M; Vicente A; Dahdouh A; Ibn Mansour A; Jiménez C; Martín D; Sarmiento RG; Medarde M; Caballero E; Peláez R
Eur J Med Chem; 2015 Jul; 100():210-22. PubMed ID: 26092446
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.
Wu X; Wang Q; Li W
Anticancer Agents Med Chem; 2016; 16(10):1325-38. PubMed ID: 26899186
[TBL] [Abstract][Full Text] [Related]
17. Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues.
Guan Q; Zuo D; Jiang N; Qi H; Zhai Y; Bai Z; Feng D; Yang L; Jiang M; Bao K; Li C; Wu Y; Zhang W
Bioorg Med Chem Lett; 2015 Feb; 25(3):631-4. PubMed ID: 25529737
[TBL] [Abstract][Full Text] [Related]
18. QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents.
Marzaro G; Chilin A
Curr Top Med Chem; 2014; 14(20):2253-62. PubMed ID: 25434357
[TBL] [Abstract][Full Text] [Related]
19. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
Lin CM; Singh SB; Chu PS; Dempcy RO; Schmidt JM; Pettit GR; Hamel E
Mol Pharmacol; 1988 Aug; 34(2):200-8. PubMed ID: 3412321
[TBL] [Abstract][Full Text] [Related]
20. Discovery of small molecule inhibitors that interact with γ-tubulin.
Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
